Clinical trial
Iron Sucrose in Stage 3/4 Kidney Disease
NCT00202345 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00202345 |
|---|---|
| Title | Iron Sucrose in Stage 3/4 Kidney Disease |
| Official title | Assessment of the Use of Intravenous Iron Sucrose to Maintain Haemoglobin Levels and Delay the Onset of Use of Erythropoietic Agents and/or Dialysis in Stage 3/4 Chronic Kidney Disease |
| Lead sponsor | Melbourne Health, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Anemia |
| Intervention type | Drug |
| Interventions | Iron sucrose |
| Enrollment | 120 |
| Start date | Aug 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | May 5, 2015 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: